FifthDelta Ltd. has recently announced that it has increased stake in Innoviz Technologies Ltd (NASDAQ:INVZ) by 15.06%. After grabbing 13.23 million shares, the institutional investor is now in possession of 1.73 million shares of the Consumer Cyclical Company. The new investment brought the stake of investor firm to 8.11% having worth around $22.63 million. Moreover, Cowen & Co. LLC increased its share by 1.33 million to have a control over 6.35 million shares. And Phoenix Investments House Ltd. raised its holdings to 4.19 million shares by acquiring 6.26 million shares or 3.83% of the stake.
Innoviz Technologies Ltd (INVZ) concluded trading on 01/10/24 at a closing price of $2.17, with 3.02 million shares of worth about $6.54 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -37.46% during that period and on Wednesday the price saw a loss of about -2.25%. Currently the company’s common shares owned by public are about 164.89M shares, out of which, 157.59M shares are available for trading.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Innoviz Technologies Ltd (NASDAQ: INVZ) started trading at $2.23, above $0.01 from concluding price of the previous day. Stock saw a price change of -11.43% in past 5 days and over the past one month there was a price change of 20.56%. Year-to-date (YTD), INVZ shares are showing a performance of -14.23% which decreased to -48.82% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.30 but also hit the highest price of $6.14 during that period. The average intraday trading volume for Innoviz Technologies Ltd shares is 4.07 million. The stock is currently trading -14.35% below its 20-day simple moving average (SMA20), while that difference is up 4.09% for SMA50 and it goes to -12.38% lower than SMA200.
FifthDelta Ltd. acquired 13.23 million shares of Innoviz Technologies Ltd having value of about $22.63 million. Data submitted at the U.S SEC by FifthDelta Ltd. revealed that the firm now holds 1.73 million shares in the company valued at close to $3758989.01, or have control over 15.06% stake in the company. Innoviz Technologies Ltd (NASDAQ: INVZ) currently have 164.89M outstanding shares and institutions hold larger chunk of about 52.20% of that. Holding of mutual funds in the company is about 46.46% while other institutional holders and individual stake holders have control over 6.35% and — of the stake respectively.
The stock has a current market capitalization of $357.81M and its 3Y-monthly beta is at 1.09. It has posted earnings per share of -$0.92 in the same period. It has Quick Ratio of 5.35 while making debt-to-equity ratio of 0.18. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for INVZ, volatility over the week remained 6.33% while standing at 9.74% over the month.
Analysts are in expectations that Innoviz Technologies Ltd (INVZ) stock would likely to be making an EPS of -$0.18 in the current quarter, while forecast for next quarter EPS is -$0.18 and it is -$0.77 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.26 which is -$0.14 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.25 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 15.24% while it is estimated to increase by 3.74% in next year.
Analysts at 5 brokerage firms have issued recommendations for the Innoviz Technologies Ltd (INVZ)’s stock and average of those rates the stock at a “Strong Buy” and assign it a score of 1.40. Out of those 5 Wall Street analysts, 4 recommended a “Buy” rating, while 1 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Rosenblatt on October 25, 2022 offering a Neutral rating for the stock and assigned a target price of $5 to it.
